Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02218853 · ClinicalTrials.gov registry record

Psychosis and Affective Research Domains and Intermediate Phenotypes

A clinical trial of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
113
Enrollment target
1
Study location

NCT02218853 is a study of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 113 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02218853, a study of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
113 participants
Enrollment target
1
Study location

Study Summary

The objective of this multi-site research collaboration is to test the manifestation and distribution of biological markers for psychosis and affect dimensions across the schizophrenia/bipolar (SZ-BD) diagnostic boundary, and to examine heritability and genetic associations for these biological markers.

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2014-04
Est. Completion 2017-12

What the Registry Record Tells You About NCT02218853

The ClinicalTrials.gov registry entry for NCT02218853 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bipolar I Disorder, Unspecified, With Psychotic Features appearing as the primary indexed condition, and to 0 interventions.

NCT02218853 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02218853 about?

NCT02218853 is a clinical study titled "Psychosis and Affective Research Domains and Intermediate Phenotypes". The objective of this multi-site research collaboration is to test the manifestation and distribution of biological markers for psychosis and affect dimensions across the schizophrenia/bipolar (SZ-BD) diagnostic boundary, and to examine heritability and genetic associations for these biological mark...

What is the current status of trial NCT02218853?

This trial is currently completed. The enrollment target is 113 participants. The study started on 2014-04. Estimated completion is 2017-12.

What conditions does trial NCT02218853 study?

This clinical trial studies the following conditions: Bipolar I Disorder, Unspecified, With Psychotic Features, Bipolar I Disorder, Unspecified, Without Psychotic Features.

Who is sponsoring clinical trial NCT02218853?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02218853 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.